These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 17284238

  • 1. Treatment of hyperactivity in children with pervasive developmental disorders.
    Scahill L, Pachler M.
    J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):59-62. PubMed ID: 17284238
    [No Abstract] [Full Text] [Related]

  • 2. Methylphenidate an effective treatment for ADHD?
    McDougle CJ.
    J Autism Dev Disord; 2004 Oct; 34(5):593-4. PubMed ID: 15628613
    [No Abstract] [Full Text] [Related]

  • 3. Introduction: new developments in the treatment of attention-deficit/hyperactivity disorder.
    Biederman J.
    J Clin Psychiatry; 2006 Oct; 67 Suppl 8():4-6. PubMed ID: 16961423
    [No Abstract] [Full Text] [Related]

  • 4. A prospective open trial of guanfacine in children with pervasive developmental disorders.
    Scahill L, Aman MG, McDougle CJ, McCracken JT, Tierney E, Dziura J, Arnold LE, Posey D, Young C, Shah B, Ghuman J, Ritz L, Vitiello B.
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):589-98. PubMed ID: 17069547
    [Abstract] [Full Text] [Related]

  • 5. [Methylphenidate. A possibility for rare hyperactive children].
    Rev Infirm; 2004 Sep; (103):39-40. PubMed ID: 15517803
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of attention-deficit-hyperactivity disorder.
    Elia J, Ambrosini PJ, Rapoport JL.
    N Engl J Med; 1999 Mar 11; 340(10):780-8. PubMed ID: 10072414
    [No Abstract] [Full Text] [Related]

  • 7. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract] [Full Text] [Related]

  • 8. Attention deficit hyperactivity disorder in children.
    Ramchandani P, Joughin C, Zwi M.
    Clin Evid; 2002 Jun 30; (7):262-71. PubMed ID: 12230649
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacotherapy for child and adolescent attention-deficit hyperactivity disorder.
    Kaplan G, Newcorn JH.
    Pediatr Clin North Am; 2011 Feb 30; 58(1):99-120, xi. PubMed ID: 21281851
    [Abstract] [Full Text] [Related]

  • 10. Clonidine for treatment of attention-deficit/hyperactivity disorder.
    Med Lett Drugs Ther; 1996 Dec 06; 38(989):109-10. PubMed ID: 8957471
    [No Abstract] [Full Text] [Related]

  • 11. Mechanism of action of alpha 2A-adrenergic agonists in attention-deficit/hyperactivity disorder with or without oppositional symptoms.
    Stahl SM.
    J Clin Psychiatry; 2010 Mar 06; 71(3):223-4. PubMed ID: 20331927
    [No Abstract] [Full Text] [Related]

  • 12. Attention deficit hyperactivity disorder in children.
    Ramchandani P, Joughin C, Zwi M.
    Clin Evid; 2002 Dec 06; (8):280-90. PubMed ID: 12603883
    [No Abstract] [Full Text] [Related]

  • 13. The run on Ritalin. Attention deficit disorder and stimulant treatment in the 1990s.
    Diller LH.
    Hastings Cent Rep; 1996 Dec 06; 26(2):12-8. PubMed ID: 8722521
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Malnutrition in children with DAMP?].
    Andersen LL.
    Ugeskr Laeger; 2009 Mar 02; 171(10):824. PubMed ID: 19280776
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Guanfacine use in children with attention deficit hyperactivity disorder.
    Cohn LM, Caliendo GC.
    Ann Pharmacother; 1997 Mar 02; 31(7-8):918-9. PubMed ID: 9220058
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anxiolytics, adrenergic agents, and naltrexone.
    Riddle MA, Bernstein GA, Cook EH, Leonard HL, March JS, Swanson JM.
    J Am Acad Child Adolesc Psychiatry; 1999 May 02; 38(5):546-56. PubMed ID: 10230186
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
    Wilens TE.
    J Clin Psychiatry; 2006 May 02; 67 Suppl 8():32-8. PubMed ID: 16961428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.